[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350082-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350082-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","angiotensin-ii-type-1-receptor-signaling-promotes-bladder-cancer-progression-and-its-inhibition-by-losartan","Angiotensin II type 1 receptor signaling promotes bladder cancer progression and its inhibition by Losartan","","The renin-angiotensin system (RAS) regulates blood pressure and has been linked to cancer biology. This study defines the role of angiotensin II type 1 receptor (AGTR1) in bladder cancer progression and evaluates the therapeutic potential of the ARB losartan (LOS). In nonmuscle-invasive bladder cancer, intravesical recurrence after TURBT correlated with AGTR1 expression. AGTR1/ERK2 signals were associated with overall survival. In AGTR1-overexpressing T24 cells, AngII increased invasion, migration, and neuronal nitric oxide synthase, triggered ERK phosphorylation with Akt dephosphorylation, and activated NF-κB, mTOR, and EMT pathways. LOS suppressed AngII-driven responses and in vivo reduced E-cadherin while increasing N-cadherin, supporting LOS repositioning and the need for AGTR1 stratification.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/angiotensin-ii-type-1-receptor-signaling-promotes-bladder-cancer-progression-and-its-inhibition-by-losartan/350082/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/angiotensin-ii-type-1-receptor-signaling-promotes-bladder-cancer-progression-and-its-inhibition-by-losartan/350082.png","ImageObject",300,407,{"name":42,"@type":43},"WPS_1786070896","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How did AGTR1 expression relate to clinical outcomes in bladder cancer patients?","Question",{"text":63,"@type":64},"In patients with primary nonmuscle-invasive bladder cancer, intravesical recurrence after TURBT correlated with AGTR1 expression levels.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What effects did Angiotensin II have on AGTR1-overexpressing T24 bladder cancer cells?",{"text":68,"@type":64},"AngII promoted invasion and migration and upregulated neuronal nitric oxide synthase without affecting proliferation. These effects involved rapid ERK phosphorylation with Akt dephosphorylation.",{"name":70,"@type":61,"acceptedAnswer":71},"How did losartan (LOS) influence the AngII/AGTR1 signaling responses and tumor progression?",{"text":72,"@type":64},"LOS suppressed AngII-mediated responses, including pathway activation and EMT-associated protein changes. In vivo, LOS treatment reduced E-cadherin and elevated N-cadherin changes associated with AGTR1-driven tumor progression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350082,1790148854,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Hypertension Research (2026) 49:1480–1494  \n[https://doi.org/10.1038/s41440-025-02535-y](https://doi.org/10.1038/s41440-025-02535-y)  \nAngiotensin II type 1 receptor signaling promotes bladder cancer progression and its inhibition by Losartan  \nRyoken Yamanaka1,2 ● Kento Miura1 ● Norimasa Yamasaki1 ● Sawako Ogata1 ● Megmi Nakamura1 ● Toshiya Inaba1 ● Anarkhuu Bold-Erdene1 ● Uyanga Enkhbaatar1 ● Fatemeh Beygom Mirkatouli1 ● Shuka Miura1 ● Naohisa Hosomi1 ● Kohei Kobatake1,2 ● Kenshiro Takemoto1,2 ● Yuki Kohada1,2 ● Ryo Tasaka1,2 ● Tomoya Hatayama1,2 ●  \nKazuma Yukihiro1,2 ● Hiroyuki Shikuma1,2 ● Kyosuke Iwane1,2 ● Nobuyuki Hinata2 ● Osamu Kaminuma1  \nReceived: 4 July 2025 / Revised: 4 December 2025 / Accepted: 17 December 2025 / Published online: 19 January 2026 © The Author(s) 2026 . This article is published with open access  \nAbstract  \nThe renin-angiotensin system (RAS) plays a central role in regulating blood pressure and has recently been implicated in cancer biology. Although angiotensin II (AngII) receptor blockers (ARBs) have shown clinical beneﬁt in bladder cancer, their mechanisms of action remain unclear. Here, we investigated the contribution of AngII type 1 receptor (AGTR1) to bladder cancer progression and assessed the therapeutic potential of the ARB losartan (LOS) . In patients with primary nonmuscle-invasive bladder cancer, intravesical recurrence following transurethral tumor resection correlated with AGTR1 expression levels. Public database analysis revealed that the expression of AGTR1 and its downstream kinases, extracellular signal-regulated kinase (ERK) 1 and ERK2, was associated with overall survival in bladder urothelial carcinoma. In AGTR1-overexpressing T24 bladder cancer cells, AngII promoted invasion and migration and upregulated neuronal nitric oxide synthase, without affecting proliferation. These effects were accompanied by rapid ERK phosphorylation alongside Akt dephosphorylation. RNA sequencing revealed that AGTR1 expression and AngII stimulation activated NF-κB, mTOR, and epithelial-mesenchymal transition (EMT) pathways. LOS suppressed these AngII-mediated responses, whereas the AngII-independent upregulation of EMT-related proteins and the enhancement of mitochondrial energy metabolism by AngII in AGTR1-overexpressing cells remained unaffected. In vivo, AGTR1 facilitated early tumor engraftment and promoted tumor progression, accompanied by reduced E-cadherin and elevated N-cadherin expression, with most of these changes suppressed by LOS treatment. In conclusion, our ﬁndings highlight the crucial role of AGTR1 in bladder cancer and support the repositioning of ARBs, such as LOS, as therapeutics for AGTR1-upregulated bladder cancer, while underscoring the importance of AGTR1 stratiﬁcation for future clinical evaluation.  \nKeywords Angiotensin II ● Angiotensin II type 1 receptor ● Bladder cancer ● Losartan ● Implemental hypertension  \nSupplementary information The online version contains supplementary material available at [https://doi.org/10.1038/s41440-](https://doi.org/10.1038/s41440-)[ ](https://doi.org/10.1038/s41440-)[025-02535-y](025-02535-y.)[.](025-02535-y.)  \n* Osamu Kaminuma [okami@hiroshima-u.ac.jp](okami@hiroshima-u.ac.jp)  \n1 Department of Disease Models, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan  \n2 Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan  \nIntroduction  \nThe renin-angiotensin system (RAS) plays a critical role in the regulation of blood pressure in humans [1] . Consequently, drugs targeting RAS, including angiotensin II type 1 receptor (AGTR1) blockers (ARBs), are widely used in the clinical management of hypertension. Like other components of metabolic syndrome, hypertension is recognized as a risk factor for the development and progression of various cancers [2] . Recently, the AGTR1 gene, which encodes the AGTR1 protein, has gathered attention as a po","cbCaiqZSBrikeItf","https://ap.wps.com/l/cbCaiqZSBrikeItf","pdf",4128722,15,"English","# Abstract\n# Introduction\n## Background: RAS and hypertension as cancer risk\n## AGTR1 as a potential oncogene across cancers\n## Bladder cancer burden and current therapies\n## Rationale: AGTR1 signaling pathways and therapeutic uncertainty","[{\"question\":\"How did AGTR1 expression relate to clinical outcomes in bladder cancer patients?\",\"answer\":\"In patients with primary nonmuscle-invasive bladder cancer, intravesical recurrence after TURBT correlated with AGTR1 expression levels.\"},{\"question\":\"What effects did Angiotensin II have on AGTR1-overexpressing T24 bladder cancer cells?\",\"answer\":\"AngII promoted invasion and migration and upregulated neuronal nitric oxide synthase without affecting proliferation. These effects involved rapid ERK phosphorylation with Akt dephosphorylation.\"},{\"question\":\"How did losartan (LOS) influence the AngII/AGTR1 signaling responses and tumor progression?\",\"answer\":\"LOS suppressed AngII-mediated responses, including pathway activation and EMT-associated protein changes. In vivo, LOS treatment reduced E-cadherin and elevated N-cadherin changes associated with AGTR1-driven tumor progression.\"}]","Angiotensin II type 1 receptor signaling promotes bladder cancer progression and its inhibition by Losartan | PDF",1790087078,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79da70f23c88751cdb20da6b9f0061dd.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad246689056022fd151cd5f7714ebdd8.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f06ce647f6e981ea7e990c053d7a91fa.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f99c80929f7f8853928da589848f0696.webp",980,1301]